[Finished Printing? - Click Here to Return to Normal View]

Glutamate Cascade Research

The Glutamate Cascade: Common Pathways of Central Nervous System Disease States

Agenda Committee


NIDA

Barbara H. Herman, Ph.D., Chair
Robert Caudle, Ph.D.
Lynda Erinoff, Ph.D.
Jerry Frankenheim, Ph.D.
Barry J. Hoffer, M.D., Ph.D.
Dave Thomas, Ph.D.
Stephen R. Zukin, M.D.

NINDS

Mary Ellen Cheung, Ph.D.
Michael A. Rogawski, M.D., Ph.D.
Philip H. Sheridan, M.D.

NIAAA

Walter Hunt, Ph.D.
Raye Z. Litten, Ph.D.

NIMH

Linda Brady, Ph.D.
Dianne Rausch, Ph.D.

NIA

Bradley Wise, Ph.D.

NIDDK

Phil Skolnick, Ph.D.
(Now at Lilly Research Laboratories)

NICHD

Ralph M. Nitkin, Ph.D.

NIDR

Mitchell B. Max, M.D.

NIAID

Tanya Lehky, M.D.
Betsy Smith, M.D.

[Index] [Program List]

NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version

National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, June 7, 2006. The U.S. government's official web portal